SSII insider trading

NasdaqCM Healthcare

SS Innovations International, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
139
Last 90 days
12
Buys / sells
58% / 8%
Market cap
$876.55M

About SS Innovations International, Inc.

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NADI – Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applicator; SSi Robotic Stapler; SSi Maya is an enabling digital platform that compliments the SSI Mantra system and enhances surgical capabilities; SSi Guru is a virtual tele illustration; SSi XR Cognitive Skill Simulator is an extended reality (XR) software platform developed to train and educate surgeons and surgical assistants; SSi MantraM; SSi Mantra Tele Surgeon Console (TSC); and 5mm surgical instruments; SSi Holographic Anatomy, an augmented reality tool; SSi Chitrasa – Advanced DICOM Viewer, an AI enabled application viewer; and SSi Mixed Reality Headset, a medical-grade device. In addition, it offers instrument tips, including forceps, scissors, electrocautery tools, scalpels, and other surgical tools. Further, the company provides accessory products, such as sterile drapes, 3d stereo endoscopes, cannulas, and seals, as well as tele proctoring and telesurgery products. Additionally, it offers installation, repair, maintenance, 24/7 technical support, and proactive health monitoring services. The company sells its products through direct sales organizations and distributor networks. SS Innovations International, Inc. is headquartered in Gurugram, India.

Company website: ssinnovations.com

SSII insider activity at a glance

FilingIQ has scored 139 insider transactions for SSII since Nov 9, 2023. The most recent filing in our index is dated May 12, 2026.

Across the full history, 81 open-market purchases and 11 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SSII insider trades is 59.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest SSII Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Top insiders trading SSII

Frequently asked

How many insider trades does FilingIQ track for SSII?
FilingIQ tracks 139 Form 4 insider transactions for SSII (SS Innovations International, Inc.), covering filings from Nov 9, 2023 onwards. 12 of those were filed in the last 90 days.
Are SSII insiders net buyers or net sellers?
Across the full Form 4 history for SSII, 81 transactions (58%) were open-market purchases and 11 (8%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SSII insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is SSII in?
SS Innovations International, Inc. (SSII) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $876.55M.

Methodology & sources

Every SSII insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.